Avaleht › Crohni tõbi › Alabama
Crohni tõbi kliinilised uuringud osariigis Alabama
9 uuringut haiguse Crohni tõbi jaoks otsivad osalejaid osariigis Alabama.
Linnad osariigis Alabama
Ametlik uuringutekst (inglise keeles)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Digestive Health Specialists /ID# 280827, Dothan
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health, Birmingham
- East View Medical Research, Mobile
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Digestive Health Specialists /ID# 266216, Dothan
- East View Medical Research /ID# 270377, Mobile
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Digestive Health Specialists of the Southeast, Dothan
- East View Medical Research, Mobile
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Digestive Health Specialists, Dothan
VärbamineFaas 3
Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Digestive Health Specialsits, Dothan
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 9. sept 2026 · NCT06045754A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- University of South Alabama (USA) Physicians Group, Mobile
VärbamineFaas 3
Vanused 2 ja vanemad · Kõik sood · Uuendatud 7. mai 2026 · NCT05442567Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- IMC Gulf Coast Gastroenterology, PC, Fairhope
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 27. apr 2026 · NCT06456593A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Birmingham
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 12. märts 2026 · NCT07113522Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.